Private limited company · founded 2012 · 13 yrs activeJachthoorndreef 4, 9940 Evergem, BelgiumKBO/BCE: BE 0501.612.041
Summary
KLUIZEN PHARMA is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €663,862 and a net result of €112,591. Equity is growing by ~19.1% per year across the filed fiscal years. Its solvency ranks better than 38% of 5651 sector peers (fiscal year 2025). The company has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals.
Financial institution: outside the modelProbability: sector outside the model
Who decides
Holdings
1
Accounts 1 d early0 of 3 deeds read
SignalsLatest accounts filed on timeShow the evidence
Checked score
Outside the general model
Checked score
A figure from 0 to 100 for financial health from the latest annual accounts: the higher, the healthier. Without a figure, the card says why. A low score is a reason to look closely at payment terms and security.
Model not applicable to financial institutions
The Checked score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 23 days before the deadline; the sector median for financial year 2024 is 14 days before the deadline, and 28% of the sector filed late.
Checked, nothing found (2)
○
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today. Usually files around 30 January (4 of the last 5 filed years within 30 days of that day).